Effects of a high-fat diet on spontaneous metastasis of Lewis lung carcinoma in plasminogen activator inhibitor-1 deficient and wild-type mice

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Yan, Lin ^a   DeMars, Lana C ^a  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FAT INTAKE; PROTEASE NEXIN I; SERPINE2 PROTEIN, MOUSE; TUMOR PROTEIN;

ANIMAL; BLOOD; FAT INTAKE; GENETICS; KNOCKOUT MOUSE; LEWIS CARCINOMA; LUNG TUMOR; METASTASIS; MOUSE; PATHOLOGY; PHARMACOLOGY;

ANIMALS; CARCINOMA, LEWIS LUNG; CYTOKINES; DIETARY FATS; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; NEOPLASM METASTASIS; NEOPLASM PROTEINS; SERPIN E2;

EID: 84908668338     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110869     Document Type: Article

References (62)

1. Janicke F, Schmitt M, Fache L, Ulm K, Harbeck N, et al. (1993) Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat 24: 195-208.
2. Seetoo DQ, Crowe PJ, Russell PJ, YangJL (2003) Quantitative expression of protein markers of plasminogen activation system in prognosis of colorectal cancer. J Surg Oncol 82: 184-193.
3. McMahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, et al. (2001) Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem 276: 33964-33968.
4. Tsuchiya H, Sunayama C, Okada G, Matsuda E, Tomita K, et al. (1997) Plasminogen activator inhibitor-1 accelerates lung metastasis formation of human fibrosarcoma cells. Anticancer Res 17: 313-316.
5. Gutierrez LS, Schulman A, Brito-Robinson T, Noria F, Ploplis VA, et al. (2000) Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Cancer Res 60: 5839-5847.
6. Bajon K, Noel A, Gerard RD, Masson V, Brunner N, et al. (1998) Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4: 923-928.
7. Maillard CM, Bouquet C, Petitjean MM, Mestdagt M, Frau E, et al. (2008) Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors. Carcinogenesis 29: 2236-2242.
8. Almholt K, Nielsen BS, Frandsen TL, Brunner N, Dano K, et al. (2003) Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 genedeficient mice. Oncogene 22: 4389-1397.
9. Eitzman DT, KraussJC, Shen T, Cui J, Ginsburg (1996) Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma. Blood 87: 4718-4722.
10. Daniell HW (1988) Increased lymph node metastases at mastectomy for breast cancer associated with host obesity, cigarette smoking, age, and large tumor size. Cancer 62: 429-435.
11. Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, et al. (2005) Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14: 1686-1691.
12. Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, et al. (2005) Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology 66: 1060-1065.
13. Amling CL, Riffenburgh RH, Sun L, Moul JW, Lance RS, et al. (2004) Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 22: 439-445.
14. McGill JB, Schneider DJ, Arfken CL, Lucore CL, Sobel BE (1994) Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 43: 104-109.
15. Alessi MC, Bas teli ca D, Moran ge P, Berthet B, Leduc I, et al. (2000) Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 49: 1374-1380.
16. Yan L, DeMars LC, Johnson LK (2012) Long-term voluntary running improves diet-induced adiposity in young adult mice. Nutr Res 32: 458-465.
17. Yan L, Graef GL, Claycombe KJ, Johnson LK (2013) Effects of voluntary running and soy supplementation on diet-induced metabolic disturbances and inflammation in mice. J Agrie Food Chem 61: 9373-9379.
18. Yan L, Combs GFJr (2014) Consumption of a high-fat diet abrogates inhibitory effects of methylseleninic acid on spontaneous metastasis of Lewis lung carcinoma in mice. Carcinogenesis 35: 2308-2313.
19. Yan L, Demars LC (2010) Effects of dietary fat on spontaneous metastasis of Lewis lung carcinoma in mice. Clin Exp Metastasis 27: 581-590.
20. Institute for Laboratory Animal Research (2011) Guide for the Care and Use of Laboratory Animals; National Research Council DoEaLS, Institute for Laboratory Animal Research, editor. Washington, D.C.: National Academies Press.
21. Reeves PG, Nielsen FH, Fahey GCJ (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951.
22. Brodt P (1986) Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities. Cancer Res 46: 2442-2448.
23. Fidler IJ (1978) General considerations for studies of experimental cancer metastasis. In: Busch H, editor. Methods in Cancer Research. New York: Academic Press. 399-439.
24. Welch DR, Neri A, Nicolson GL (1983) Comparison of 'spontaneous' and 'experimental' metastasis using rat 13726 mammary adenocarcinoma metastatic cell clones. Invasion Metastasis 3: 65-80.
25. Ortega FJ, Moreno-Navarrete JM, Mayas D, Garcia-Santos E, Gomez-Serrano M, et al. (2012) Breast cancer 1 (BrCal) may be behind decreased lipogenesis in adipose tissue from obese subjects. PLoS One 7: e33233.
26. Liu G, Shuman MA, Cohen RL (1995) Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int J Cancer 60: 501-506.
27. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, et al. (2000) Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96: 34-40.
28. Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, et al. (2007) The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 67: 585-592.
29. Waters JP, Pober JS, Bradley JR (2013) Tumour necrosis factor and cancer. J Pathol 230: 241-248.
30. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, et al. (1998) Biological action of leptin as an angiogenic factor. Science 281: 1683-1686.
31. Rene Gonzalez R, Watters A, Xu Y, Singh UP, Mann DR, et al. (2009) Leptinsignaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res 11: R36.
32. Yan L, Demars LC (2012) Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice. Int J Cancer 131: 1260-1266.
33. Kopitz C, Gerg M, Bandapalli OR, Ister D, Pennington CJ, et al. (2007) Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res 67: 8615-8623.
34. Dool CJ, Mashhedi H, Zakikhani M, David S, Zhao Y, et al. (2011) IGF1/ insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer. Endocr Relat Cancer 18: 699-709.
35. Fierz Y, Novosyadlyy R, Vijayakumar A, Yakar S, LeRoith D (2010) Insulinsensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression. Diabetes 59: 686-693.
36. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, et al. (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25: 5287-5312.
37. Blake CM, Sullenger BA, Lawrence DA, Fortenberry YM (2009) Antimetastatic potential of PAI-1-specific RNA aptamers. Oligonucleotides 19: 117-128.
38. HennanJK, Elokdah H, Leal M, Ji A, Friedrichs GS, et al. (2005) Evaluation of PAI-039 [{TbenzyT5-[4-(trifluoromethoxy)phenyl]TH-indoT3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis. J Pharmacol Exp Ther 314: 710-716.
39. Leik CE, Su EJ, Nambi P, Crandall DL, Lawrence DA (2006) Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis. J Thromb Haemost 4: 2710-2715.
40. Kruithof EK, Gudinchet A, Bachmann F (1988) Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states. Thromb Haemost 59: 7-12.
41. Sawdey MS, Loskutoff DJ (1991) Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest 88: 1346-1353.
42. Quax PH, van den Hoogen CM, Verheijen JH, Padro T, Zeheb R, et al. (1990) Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem 265: 15560-15563.
43. Phoenix KN, Vumbaca F, Fox MM, Evans R, Claffey KP (2010) Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy. Breast Cancer Res Treat 123: 333-344.
44. Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, et al. (2003) Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Ob es Res 11: 368-372.
45. Schwartz MW, Woods SC, Porte D, Jr., Seeley BJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404: 661-671.
46. Morange PE, Lijnen HR, Alessi MC, Kopp F, Collen D, et al. (2000) Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. Arterioscler Thromb Vasc Biol 20: 1150-1154.
47. Czekay RP, Loskutoff DJ (2004) Unexpected role of plasminogen activator inhibitor 1 in cell adhesion and detachment. Exp Biol Med (Maywood) 229: 1090-1096.
48. Ueno T, Toi M, Saji H, Muta M, Bando H, et al. (2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6: 3282-3289.
49. Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissiere F, et al. (2007) Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res 9: R15.
50. Ferrajoli A, Keating MJ, Manshouri T, Giles FJ, Dey A, et al. (2002) The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia. Blood 100: 1215-1219.
51. Guo RP, Zhong C, Shi M, Zhang CQ, Wei W, et al. (2006) Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. J Cancer Res Clin Oncol 132: 547-555.
52. Ree AH, Florenes VA, Berg JP, Maelandsmo GM, NeslandJM, et al. (1997) High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases. Clin Cancer Res 3: 1623-1628.
53. Kimura Y, Sumiyoshi M (2007) High-fat, high-sucrose, and high-cholesterol diets accelerate tumor growth and metastasis in tumor-bearing mice. Nutr Cancer 59: 207-216.
54. Okahara H, Yagita H, Miyake K, Okumura K (1994) Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAMT) in tumor necrosis factor alpha enhancement of experimental metastasis. Cancer Res 54: 3233-3236.
55. Achbarou A, Kaiser S, Tremblay G, Ste-Marie LG, Brodt P, et al. (1994) Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res 54: 2372-2377.
56. Kido A, Tsutsumi M, Iki K, Takahama M, Tsujiuchi T, et al. (1999) Overexpression of matrix metalloproteinase (MMP)-9 correlates with metastatic potency of spontaneous and 4-hydroxyaminoquinoline 1-oxide (4-HAQO)induced transplantable osteosarcomas in rats. Cancer Lett 137: 209-216.
57. th Edition, 2006). Corn Refiners Association website. Available: http://www.corn.org/wp-content/uploads/2009/12/CornOil.pdf. 1-22. Accessed 2014 Oct 7.
58. Barcelo-Coblijn G, Murphy EJ (2009) Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res 48: 355-374.
59. Gerber M (2012) Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr 107 Suppl 2: S228-239.
60. Algamas-Dimantov A, Davidovsky D. Ben-Ari J. Kang JX, Peri I, et al. (2012) Amelioration of diabesity-induced colorectal ontogenesis by omega-3 fatty acids in mice. J Lipid Res 53: 1056-1070.
61. Kockx M, Leenen R, Seidell J, Princen HM, Kooistra T (1999) Relationship between visceral fat and PAI-1 in overweight men and women before and after weight loss. Thromb Haemost 82: 1490-1496.
62. Mavri A, Stegnar M, Krebs M. Sentocnik JT. Geiger M. et al. (1999) Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women. Arterioscler Thromb Vase Biol 19: 1582-1587.